Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) reported its financial results for the first quarter of 2026, revealing $956.6 million in working capital, $36 million in revenue, and $8.3 million in cash from operating activities. The company also reduced its net loss to $10.8 million, while producing 790,000 pounds of finished U3O8. These results underscore Energy Fuels' continued strength as a U.S.-based producer of uranium, rare earth elements (REEs), and critical minerals.
The company's strong working capital position provides a solid foundation for advancing its portfolio of uranium, rare earth, and mineral sands development initiatives. Energy Fuels has been the top U.S. producer of natural uranium concentrate, supplying nuclear utilities, and owns the only fully licensed conventional uranium mill operating in the U.S.—the White Mesa Mill in Utah. At this mill, the company also produces REE products and evaluates medical isotope recovery for emerging cancer therapies.
Beyond uranium, Energy Fuels is advancing three heavy mineral sands/rare earths projects: the Vara Mada Project in Madagascar, the Bahia Project in Brazil, and the Donald Project in Australia through a joint venture with Astron Limited. These projects are expected to further diversify the company's critical materials portfolio and strengthen its role in the global supply chain for rare earth elements.
The company's Q1 results and ongoing developments are significant given the increasing demand for uranium and rare earth elements, which are essential for clean energy technologies and national security. Energy Fuels' strategic positioning in the U.S. and its international projects aim to reduce reliance on foreign sources for these critical materials.
For more details, the full press release is available at https://ibn.fm/r07Hd. Additional news and updates on Energy Fuels can be found at http://ibn.fm/UUUU.
Energy Fuels is a leading U.S. critical materials company specializing in uranium, rare earth elements, heavy mineral sands, vanadium, and the development of medical isotopes. Based in Lakewood, Colorado, its shares trade on the NYSE American under the symbol “UUUU” and on the TSX under “EFR.”
